1. Home
  2. MDXH

MDXH

MDxHealth SA

Logo MDxHealth SA

as 04-22-2024 10:31am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

Founded: 2003 Country:
Belgium
Belgium
Employees: N/A City: N/A
Market Cap: 62.8M IPO Year: 2021
Target Price: $7.33 AVG Volume (30 days): 75.1K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -16.60 EPS Growth: N/A
52 Week Low/High: $0.35 - $4.64 Next Earning Date: 05-08-2024
Revenue: $70,193,000 Revenue Growth: 89.43%
Revenue Growth (this year): 16.15% Revenue Growth (next year): 14.21%

Share on Social Networks: